nach oben

Journal of Neurology

Erschienen in:

01.05.2009 | Review

Multisystem manifestations of mitochondrial disorders

verfasst von: Stefano Di Donato

Erschienen in: Journal of Neurology | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Mitochondria are cytoplasmic organelles in eukaryotic cells that accomplish several distinct vital functions, including oxidative phosphorylation, metabolic anaplerotic and degradative pathways, and integration of signaling for apoptosis. Impaired oxidative phosphorylation, the common final pathway of mitochondrial metabolism, results in a variety of clinical manifestations, and the term mitochondrial disorders is currently ascribed to (mostly) genetic diseases of the respiratory chain associated with mitochondrial DNA mutation or nuclear DNA mutations. Genetic disorders with impaired oxidative phosphorylation are extremely heterogeneous, as their clinical presentation ranges from lesions of single tissues or specialized structures, such as the optic nerve in the mitochondrial DNA-associated Leber’s hereditary optic neuropathy and in the nuclear DNA-associated dominant optic atrophy, to more widespread pathologies, including myopathies, peripheral neuropathies, encephalomyopathies, cardiopathies, or complex multisystem disorders. The age at onset ranges from neonatal to adult life. This review focuses on mitochondrial diseases that find significant expression outside the central nervous system and the peripheral neuromuscular system, and manifest with substantial clinical signs and symptoms in tissues and organs such as the heart, endocrine system, liver, kidney, blood, and gastrointestinal tract. The available information on putative genotype–phenotype correlations and the related pathogenic mechanisms are summarized when appropriate.

Nur mit Berechtigung zugänglich

Alcolado JC, Laji K, Gill-Randall R (2002) Maternal transmission of diabetes. Diabet Med 19:89–98

Alexander C, Votruba M, Pesch UEA, Thiselton DL, Mayer S, Moore A, Rodriquez M, Kellner U, Leo-Kottler B, Auburger G, Bhattcharya SS, Wissinger B (2000) OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 26:211–215

Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, Koeller D (1999) Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 8:743–749

Andreu AL, Hanna MG, Reichmann H, Bruno C, Penn AS, Tanji K, Pallotti F, Iwata S, Bonilla E, Lach B, Morgan-Hughes J, Sl DiMauro (1999) Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med 341:1037–1044

Ankel-Simons F, Cummins JM (1996) Misconceptions about mitochondria and mammalian fertilization: implications for theories on human evolution. Proc Natl Acad Sci USA 93:13859–13863

Antonicka H, Leary SC, Guercin GH, Agar JN, Horvath R, Kennaway NG, Harding CO, Jaksch M, Shoubridge EA (2003) Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency. Hum Mol Genet 12:2693–2702

Antonicka H, Mattman A, Carlson CG, Glerum DM, Hoffbuhr KC, Leary SC, Kennaway NG, Shoubridge EA (2003) Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy. Am J Hum Genet 72:101–114

Antozzi C, Zeviani M (1997) Cardiomyopathies in disorders of oxidative metabolism. Cardiovasc Res 35:184–199

Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skoldberg F, Husebye ES, Eng C, Maher ER (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69:49–54

10.

Babcock GT, Wikström M (1992) Oxygen activation and the conservation of energy in cell respiration. Nature 356:301–309

11.

Ballinger SW, Shoffner JM, Hedaya EV, Trounce I, Polak MA, Wallace DC (1992) Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1:11–15

12.

Baughman JM, Mootha VK (2006) Buffering mitochondrial DNA variation. Nat Genet 38:1232–1233

13.

Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN, Richard CW, Cornelisse CJ, Devilee P, Devlin B (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848–851

14.

Baysal BE, Willet-Brozic JE, Lawrence EC, Drodlic CM, Savul SA, McLeod DR, Yee A, Brackmann DE, Slattery WH 3rd, Myers EN, Ferrel LE, Rubinstein WS (2002) Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet 39:178–183

15.

Benit P, Beugnot R, Chretien D, Giurgea I, De Lonlay- Debeney P, Issartel JP, Corral-Debrinski M, Kerscher S, Rustin P, Rotig A, Munnich A (2003) Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy. Hum Mutat 21:582–586

16.

Bernes SM, Bacino C, Prezant TR, Pearson MA, Wood TS, Fournier P, Fischel-Ghodsian N (1993) Identical mitochondrial DNA deletion in mother with progressive external ophthalmoplegia and son with Pearson marrow-pancreas syndrome. J Pediatr 123:598–602

17.

Betts J, Barron MJ, Needham SJ, Schaefer AM, Taylor RW, Turnbull DM (2008) Gastrointestinal tract involvement associated with the 3243A>G mitochondrial DNA mutation. Neurology 70:1290–1292

18.

Bione S, D’Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D (1996) A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nat Genet 12:385–389

19.

Bornstein B, Area E, Flanigan KM, Ganesh J, Jayakar P, Swoboda KJ, Coku J, Naini A, Shanske S, Tanji K, Hirano M, DiMauro S (2008) Mitochondrial DNA depletion syndrome due to mutations in the RRM2B gene. Neuromuscul Disord 18:453–459

20.

Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, Chretien D, de Lonlay P, Paquis-Flucklinger V, Arakawa H, Nakamura Y, Munnich A, Rotig A (2007) Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 39:776–780

21.

Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, Munnich A, Rotig A (1995) Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1:144–149

22.

Campuzano V, Montermini L, Molto MD, Pianese L, Cosseè M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Canizes J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Trouillas P, De Michele F, Filla A, De Frutos R, Palau F, Patel PI, Di Donato S, Mandel JL, Cocozza S, Koenig M, Pandolfo M (1996) Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423–1427

23.

Casali C, Santorelli FM, D’Amati G, Bernucci P, DeBiase L, DiMauro S (1995) A novel mtDNA point mutation in maternally inherited cardiomyopathy. Biochem Biophys Res Commun 213:588–593

24.

Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R, Durr A, Fontaine B, Ballabio A (1998) Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93:973–983

25.

Chinnery PF, Zeviani M (2008) 155th ENMC Workshop: Polymerase Gamma and Disorders of Mitochondrial DNA Synthesis, 21–23 September 2007, Naarden, The Netherlands. Neuromuscul Disord 18:259–267

26.

Cree LM, Samuels DC, a Lopez SC, Rajasimha HK, Wonnapinij P, Mann JR, Dahl HHM, Chinnery PF (2008) A reduction of mitochondrial DNA molecules during embriogenesis explains the rapid segregation of genotypes. Nat Genet 40:249–254

27.

de Lonlay P, Valnot I, Barriento A, Gorbatyuk M, Tzagaloff A, Taanman JW, Benayoun E, Chretien D, Kadhm N, Lombes A, de Baulny HO, Niaudet P, Munnich A, Rustin P, Rotig A (2001) A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy encephalopathy and liver failure. Nat Genet 29:57–60

28.

De Meirleir L, Seneca S, Lissens W, De Clercq I, Eyskens F, Gerlo E, Smet J, Van Coster R (2004) Respiratory chain complex V deficiency due to a mutation in the assembly gene ATP12. J Med Genet 41:120–124

29.

Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, Hamel CP (2000) Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26:207–210

30.

Di Donato S (2000) Disorders related to mitochondrial membranes: pathology of the respiratory chain and neurodegeneration. J Inherit Metab Dis 23:247–263

31.

DiMauro S, Quinzii CM, Hirano M (2007) Mutations in coenzyme Q biosynthetic enzymes. J Clin Invest 117:587–589

32.

DiMauro S, Schon E (2008) Mitochondrial disorders in the nervous system. Annu Rev Neurosci 31:91–123

33.

Dunning CJR, McKenzie M, Sugiana C, Lazarou M, Silke J, Connelly A, Fletcher JM, Kirby DM, Thorburn DR, Ryan MT (2007) Human CIA30 is involved in the early assembly of mitochondrial complex I and mutations in its gene cause disease. EMBO J 26:3227–3237

34.

Elliot HR, Samuels DC, Eden JA, Relton CL, Chinnery PF (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83:254–260

35.

Elpeleg O, Miller C, Hershkowitz E, Bitter-Glindzicz M, Bondi-Rubinstein G, Rahman S, Pagnamenta A, Eshar S, Saada A (2005) Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 76:1081–1086

36.

Estivill X, Govea N, Barcelò E, Badenas C, Romero E, Moral L, Scozzri R, D’Urbano L, Zeviani M, Torroni A (1998) Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by tretment with aminoglycosides. Am J Hum Genet 62:27–35

37.

Eviatar L, Shanske S, Gauthier B, Abrams C, Maytal J, Slavin M, Valderrama E, DiMauro S (1990) Kearns–Sayre syndrome presenting as renal tubular acidosis. Neurology 40:1761–1763

38.

Fan W, Waymire KG, Narula N, Li P, Rocher C, Coskun PE, Vannan MA, Narula J, MacGregor GR, Wallace DC (2008) A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science 319:958–962

39.

Fernadez-Vizarra E, Tiranti V, Zeviani M (2009) Assembly of the oxidative phosphorylation system in humans: What we have learned by studying its defects. Biochim Biophys Acta 1793:200–211

40.

Finocchiaro G, Baio G, Micossi P, Pozza G, Di Donato S (1988) Glucose metabolism alterations in Friedreich’s ataxia. Neurology 38:1292–1294

41.

Gamez J, Playàn A, Andreu AL, Bruno C, Navarro C, Cervera C, Arbòs MA, Schwartz S, Enriquez JA, Montoya J (1998) Familial multiple symmetric lipomatosis associated with the A8344G mutation of mitochondrial DNA. Neurology 51:258–260

42.

Gattermann N, Retzlaff S, Wang YL, Hofhaus G, Heinisch J, Aul C, Schneider W (1997) Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia. Blood 90:4961–4972

43.

Giles RE, Blanc H, Cann HM, Wallace DC (1980) Maternal inheritance of human mitochondrial DNA. Proc Natl Acad Sci USA 77:6715–6719

44.

Goto Y, Nonaka I, Horai S (1990) A mutation in tRNALeu(UUR) gene associated with MELAS subgroup of mitochondrial encephalomyopathies. Nature 348:651–653

45.

Grasso M, Diegoli M, Brega A, Campana C, Tavazzi L, Arbustini E (2001) The mitochondrial DNA mutation T12297C affects a highly conserved nucleotide of tRNALeu(CUN) and is associated with dilated cardiomyopathy. Eur J Hum Genet 9:311–315

46.

Guery B, Choukroun G, Noel LE, Clavel P, Rotig A, Lebon S, Rustin P, Bellane-Chantelotte D, Mougenot B, Grunfeld F, Chauveau D (2003) The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation. J Am Soc Nephrol 14:2099–2108

47.

Hammans HR, Sweeney MG, Hanna MG, Brockington M, Morgan-Hughes JA, Harding AE (1995) The mitochondrial DNA transfer RNA Leu(UUR) A→G (3243) mutation: A clinical and genetic study. Brain 118:721–734

48.

Hanna MG, Nelson I, Sweeney MG, Cooper JM, Watkins PJ, Morgan-Hughes JA, Harding AE (1995) Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus: different phenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation. Am J Hum Genet 56:1026–1033

49.

Hao H, Bonilla E, Manfredi G, DiMauro S, Moraes CT (1995) Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes mellitus. Am J Hum Genet 56:1017–1025

50.

Haut S, Brivet M, Touati G, Rustin P, Lebon S, Garcia-Cazorla A, Saudubray JM, Boutron A, Legrand A, Slama A (2003) A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycaemia and lactic acidosis. Hum Genet 113:118–122

51.

Hinson JT, Fantin VR, Schönberger J, Breivik N, Siem G, McDonough B, Sharma P, Keogh I, Godinho R, Santos F, Esparza A, Nicolau Y, Selvaag E, Cohen BH, Hoppel CL, Tranebjaerg L, Eavey RD, Seidman JG, Seidman CE (2007) Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome. New Engl J Med 356:809–819

52.

Hirano M, Ricci E, Koensberger R (1992) MELAS: an original case and clinical criteria for diagnosis. Neuromuscul Disord 2:125–135

53.

Hirano M, Nishigahi I, Martì R (1994) Mitochondrial neuro-gastrointestinal encephalopathy (MNGIE): a disease of two genomes. Neurologist 10:8–17

54.

Horvath R, Hudson G, Ferrari G, Futterer N, Ahola S, Lamantea E, Prokisch H, Lochmuller H, McFarland R, Ramesh V, Klopstock R, Freisinger P, Salvi F, Mayr JA, Santer R, Tesarova M, Zeman J, Udd B, Taylor RW, Turnbull D, Suomalainen A, Zeviani M, Chinnery PF (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129:1674–1684

55.

Hsieh RH, Li JY, Pang CY, Wei YH (2001) A novel mutation in the mitochondrial 16S rRNA gene in a patient with MELAS syndrome, diabetes mellitus, hyperthyroidism and cardiomyopathy. J Biomed Sci 8:328–335

56.

Hutchin TP, Cortopassi GA (2000) Mitochondrial defects and hearing loss. Cell Mol Life Sci 57:1927–1937

57.

Jaksch M, Ogilvie I, Yao J, Kortenhaus G, Bresser HG, Gerbitz KD, Shoubridge EA (2000) Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency. Hum Mol Genet 9:795–801

58.

Janssen RJ, Nijtmans LG, van den Heuvel LP, Smeitink JAM (2006) Mitochondrial complex I: structure, function and pathology. J Inherit Metab Dis 29:499–515

59.

Jonckheere AI, Hogeveen M, Nijtmans LG, van den Brandt MA, Janssen AJ, Diepstra JH, van den Brandt FC, van den Heuvel LP, Hol FA, Hofste TG, Kapusta L, Dillmann U, Shamdeen MG, Smeitink JA, Rodenburg RJ (2008) A novel mitochondrial ATP8 gene mutation in a patient with atypical hypertrophic cardiomyopathy and neuropathy. J Med Gen 45:129–133

60.

Kameoka K, Isotani H, Tanaka K, Azukari K, Fujimura Y, Shiota Y, Sasaki E, Majima M, Furukawa K, Haginomori S, Kitaoka H, Ohsawa N (1998) Novel mitochondrial DNA mutation in tRNA(Lys) (8296A → G) associated with diabetes. Biochem Biophys Res Commun 245:523–527

61.

Kaukonen J, Juselius JK, Tiranti V, Kittala A, Zeviani M, Comi JP, Keranen S, Peltonen L, Suomalainen A (2000) Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289:782–785

62.

Krishnan KJ, Reeve AK, Samuels DC, Chinnery PF, Blackwood JK, Taylor RW, Wanrooij S, Spelbrink JN, Lightowlers RN, Turnbull DM (2008) What causes mitochondrial DNA deletions in human cells? Nat Genet 40:275–279

63.

Lee WS, Sokol RJ (2007) Mitochondrial hepathopathies: advances in genetics and pathogenesis. Hepathology 45:1555–1565

64.

Leigh D (1951) Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatr 14:216–221

65.

Loeffen J, Elpeleg O, Smeitink J, Smeets R, Stockler-Ipsiroglu S, Mandel H, Sengers R, Trijbels F, van den Heuvel L (2001) Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol 49:195–201

66.

Lynn S, Wardell T, Johnson MA, Chinnery PF, Daly ME, Walker M, Turnbull DM (1998) Mitochondrial diabetes: investigation and identification of a novel mutation. Diabetes 47:1800–1802

67.

Malfatti E, Bugiani M, Invernizzi F, de Souza CF, Farina L, Carrara F, Lamantea E, Antozzi C, Confalonieri P, Sanseverino MT, Giugliani R, Uziel G, Zeviani M (2007) Novel mutations in complex I deficiency associated with mitochondrial encephalopathy. Brain 130:1894–1904

68.

Mandel H, Szargel R, Labay V, Elpeleg O, Saada A, Shalata A, Anbinder I, Berkowitz D, Hartman C, Barak M, Eriksson S, Cohen N (2001) The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29:337–341

69.

Maniura-Weber K, Taylor RW, Johnson MA, Chrzanowska-Lightowlers Z, Morris AA, Charlton CP, Turnbull DM, Bindoff LA (2004) A novel point mutation in the mitochondrial tRNA(Trp) gene produces a neurogastrointestinal syndrome. Eur J Hum Genet 12:509–512

70.

Manouvrier S, Rotig A, Hannebique G, Gheerbrandt JD, Royer-Legrain G, Munnich A, Parent M, Grunfeld JP, Largilliere C, Lombes A, Bonnefont JP (1995) Point mutation of the mitochondrial tRNALeu gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness. J Med Genet 32:654–656

71.

Marti R, Spinazzola A, Nishino I, Andreu AL, Naini A, Tadesse S, Oliver JA, Hirano M (2002) Mitochondrial neurogastrointestinal encephalomyopathy and thymidine metabolism: results and hypotheses. Mitochondrion 2:143–147

72.

Massa V, Fernandez-Vizarra E, Alshahwan S, Bakhsh E, Goffrini P, Ferrero I, Mereghetti P, D’Adamo P, Gasparini P, Zeviani M (2008) Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome C oxidase. Am J Hum Genet 82:1281–1289

73.

Merante F, Tein I, Benson L, Robinson BH (1994) Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA(glycine) gene. Am J Hum Genet 55:437–446

74.

Merante F, Myint T, Tein I, Benson L, Robinson BH (1996) An additional mitochondrial tRNA(Ile) point mutation (A-to-G at nucleotide 4295) causing hypertrophic cardiomyopathy. Hum Mutat 8:216–222

75.

Mita S, Schmidt B, Schon EA, DiMauro S, Bonilla E (1989) Detection of deleted mitochondrial genomes in cytochrome c oxidase-deficient muscle fibers of a patient with Kearns–Sayre syndrome. Proc Natl Acad Sci USA 86:9509–9513

76.

Moraes CT, Shanske S, Tritschler HJ, Aprille JR, Andreetta F, Bonilla E, Schon EA, DiMauro S (1991) mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 48:492–501

77.

Niaudet P, Heidet L, Munnich A, Schmitz J, Bouissou F, Gubler MC, Rotig A (1994) Deletion of the mitochondrial DNA in a case of de Toni–Debre–Fanconi syndrome and Pearson syndrome. Pediatr Nephrol 8:164–168

78.

Niaudet P (1998) Mitochondrial disorders and the kidney. Arch Dis Child 78:387–390

79.

Niemann S, Muller U (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26:268–270

80.

Nishino I, Spinazzola A, Hirano M (1999) Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283:689–692

81.

Ostergaard E (2008) Disorders caused by deficiency of succinate-Coenzyme A ligase. J Inherit Metab Dis (in press)

82.

Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, Sadlock JE, Krishna S, Walker W, Selby J, Glerum DM, Coster RV, Lyon G, Scalais E, Lebel R, Kaplan P, Shanske S, De Vivo DC, Bonilla E, Bonilla E, Hirano M, DiMauro S, Schon EA (1999) Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 23:333–337

83.

Piruat JI, Lopez-Barneo J (2005) Oxygen tension regulates mitochondrial DNA-encoded complex I gene expression. J Biol Chem 52:42676–42684

84.

Poulton J, O’Rahilly S, Morten KJ, Clark A (1995) Mitochondrial DNA, diabetes and pancreatic pathology in Kearns–Sayre syndrome. Diabetologica 38:868–871

85.

Poyton RO, McEwen JE (1996) Crosstalk between nuclear and mitochondrial genomes. Ann Rev Biochem 65:563–607

86.

Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, Amos KS, Cortopassi GA, Jaber L, Rotter JI, Shohat M, Fishel-Ghodsian N (1993) Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 4:289–294

87.

Quinzii CM, Hirano M, DiMauro S (2007) CoQ10 deficiency diseases in adults. Mitochondrion 7:S122–S126

88.

Rajasimha HK, Chinnery PF, Samuels DC (2008) Selection against pathogenic mtDNA mutations in a stem cell population leads to the loss of the 3243A → G mutation in blood. Am J Hum Genet 82:333–343

89.

Roberts NK, Perloff JK, Kark RAP (1979) Cardiac conduction in the Kearns–Sayre syndrome: a neuromuscular disorder associated with progressive external ophthalmoplegia and pigmentary retinopathy. Am J Cardiol 44:1396–1400

90.

Roesch K, Curran SP, Tranebjaerg L, Koehler CM (2002) Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex. Hum Mol Genet 11:477–486

91.

Rötig A, Cormier V, Blanche S, Bonnefont JP, Ledeist F, Romero N, Schmitz J, Rustin P, Fischer A, Saudubray JM (1990) Pearson’s marrow-pancreas syndrome A multi-system mitochondrial disorder in infancy. J Clin Invest 86:1601–1608

92.

Rötig A, Bessis JL, Romero N, Cormier V, Saudubray JM, Narcy P, Lenoir G, Rustin P, Munnich A (1992) Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus and cerebellar ataxia. Am J Hum Genet 50:364–370

93.

Rötig A, Mollet J, Rio M, Munnich A (2007) Infantile and pediatric quinone deficiency diseases. Mitochondrion 7S:S112–S121

94.

Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O (2001) Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29:342–344

95.

Santorelli FM, Mak SC, El-Schahawi M, Casali C, Shanske S, Baram TZ, Madrid RE, DiMauro S (1996) Maternally inherited cardiomyopathy and hearing loss associated with a novel mutation in the mitochondrial tRNALys gene (G8363A). Am J Hum Genet 58:933–939

96.

Santorelli FM, Tessa A, D’Amati G, Casali C (2001) The emerging concept of mitochondrial cardiomyopathies. Am Heart J 141:1–14

97.

Saraste M (1999) Oxidative phosphorylation at the fin de siecle. Science 283:1488–1492

98.

Sarzi E, Goffart S, Serre V, Chretien D, Slama A, Munnich A, Spelbrink JN, Rötig A (2007) Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol 62:579–587

99.

Scaglia F, Vogel H, Hawkins EP, Vladutiu GD, Liu LL, Wong LJ (2003) Novel homoplasmic mutation in the mitochondrial tRNATyr gene associated with atypical mitochondrial cytopathy presenting with focal segmental glomerulosclerosis. Am J Med Genet 123A:172–178

100.

Schaefer AM, McFarland R, Blakely EL, He L, Whittaker RG, Taylor RW, Chinnery PF, Turnbull DM (2008) Prevalence of mitochondrial DNA disease in adults. Ann Neurol 63:35–39

101.

Schon EA, Rizzuto R, Moraes CT, Nakase H, Zeviani M, DiMauro S (1989) A direct repeat is a hotspot for large-scale deletions of human mitochondrial DNA. Science 244:346–349

102.

Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC (1990) Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 61:931–937

103.

Silvestri G, Santorelli FM, Shanske S, Whitley CB, Schimmenti LA, Smith SA, DiMauro S (1994) A new mtDNA mutation in the tRNALeu (UUR) gene associated with maternally inherited cardiomyopathy. Hum Mutat 3:37–43

104.

Simonsz HJ, Barlocher K, Rotig A (1992) Kearns-Sayre’s syndrome developing in a boy who survived Pearson’s syndrome caused by mitochondrial DNA deletion. Doc Ophthalmol 82:73–79

105.

Smeitink JA, Zeviani M, Turnbull DM, Jackobs HT (2006) Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab 3:9–13

106.

Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP (2001) Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 28:223–231

107.

Spinazzola A, Viscomi C, Fernandez-Vizarra E, Carrara F, D’Adamo P, Calvo S, Marsano RM, Donnini C, Weiher H, Strisciuglio P, Parini R, Sarzi E, Chan A, DiMauro S, Rotig A, Gasparini P, Ferrero I, Mootha VK, Tiranti V, Zeviani M (2006) MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 38:570–575

108.

Spinazzola A, Santer R, Akman OH, Tsiakas K, Schaefer H, Ding X, Karadimas CL, Shanske S, Ganesh J, Di Mauro S, Zeviani M (2008) Hepatocerebral form of mitochondrial DNA depletion syndrome: novel MPV17 mutations. Arch Neurol 65:1108–1113

109.

Sweeney MG, Brockington M, Weston MJ, Morgan-Hughes JA, Harding AE (1993) Mitochondrial DNA transfer RNA mutation Leu(UUR)A → G 3260: a second family with myopathy and cardiomyopathy. Q J Med 86:435–438

110.

Taroni F, Di Donato S (2004) Pathways to motor incoordination: the inherited ataxias. Nat Rev Neurosci 5:641–655

111.

Tatuch Y, Christodoulou J, Feigenbaum A, Clarke JT, Wherret J, Smith C, Rudd N, Petrova Benedict R, Robinson BH (1992) Heteroplasmic mtDNA mutation (T → G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 50:852–858

112.

Taylor RW, Giordano C, Davidson MM, d’Amati G, Bain H, Hayes CM, Leonard H, Barron MJ, Casali C, Santorelli FM, Hirano M, Lightowlers RN, DiMauro S, Turnbull DM (2003) A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy. J Am Coll Cardiol 41:1786–1796

113.

Taylor RW, Turnbull DM (2005) Mitochondrial DNA mutations in human disease. Nat Rev Genet 6:389–402

114.

Tiranti V, Hoertnagel K, Carrozzo R, Galimberti C, Munaro M, Granatiero M, Zelante L, Gasparini P, Marzella R, Rocchi M, Bayona-Bafaluy MP, Enrique JA, Uziel G, Bertini E, Dionisi-Vici C, Franco B, Meitinger T, Zeviani M (1998) Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 63:1609–1621

115.

Tiranti V, D’Adamo P, Briem E, Ferrari G, Mineri R, Lamantea E, Mandel H, Balestri P, Garcia-Silva MT, Vollmer B, Rinaldo P, Hahn SH, Leonard J, Rahman S, Dionisi-Vici C, Garavaglia B, Gasparini P, Zeviani M (2004) Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74:239–252

116.

Tzen CY, Tsai JD, Wu TY, Chen BF, Chen ML, Lin SP, Chen SC (2001) Tubulointerstitial nephritis associated with a novel mitochondrial point mutations. Kidney Internat 59:846–854

117.

Valianpour F, Wanders RJ, Overmars H, Vreken P, Van Gennip AH, Baas F et al (2002) Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts. J Pediatr 141:729–733

118.

Valnot I, Kassis J, Chretien D, de Lonlay P, Parfait B, Munnich A, Kashaner J, Rustin P, Rotig A (1999) A mitochondrial cytochrome b mutation but no mutations of nuclearly encoded subunits in ubiquinol cytochrome c reductase (complex III) deficiency. Hum Genet 104:460–466

119.

Valnot I, Osmond S, Gigarel N, Mehaye B, Amiel J, Cormier-Daire V, Munnich A, Bonnefont JP, Rustin P, Rotig A (2000) Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 67:1104–1109

120.

Valnot I, von Kleist-Retzof JC, Barrientos A, Gorbatyuk M, Mehaye B, Rustin P, Tzagoloff A, Munnich A, Rotig A (2000) A mutation in the human heme A: farnesyltransferase gene (COX10) causes cytochrome c oxidase deficiency. Hum Mol Genet 9:1245–1249

121.

van den Ouweland JM, Lemkes HHP, Ruitenbeek W, Sandkjujl LA, deVijlder MF, Struyvenberg PA, van de Kam JJP, Maassen JA (1992) Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1:368–371

122.

Van Goethem G, Dermaut B, Lofgren A, Martin JJ, Van Broeckhoven C (2001) Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28:211–212

123.

Verma A, Piccoli DA, Bonilla E, Berry GT, DiMauro S, Moraes CT (1997) A novel mitochondrial G8313A mutation associated with prominent initial gastrointestinal symptoms and progressive encephaloneuropathy. Pediatr Res 42:448–454

124.

Visapaa I, Fellman V, Vesa J, Dasvarma A, Hutton JL, Kumar V, Payne GS, Makarow M, Van Coster R, Taylor RW, Turnbull DM, Suomalainen A, Peltonen L (2002) GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 71:863–876

125.

Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJ 2nd, Nikoskelainen EK (1988) Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 242:1427–1430

126.

Wallace DC, Zheng XX, Lott MT, Shoffner JM, Hodge JA, Kelley RI, Epstein CM, Hopkins LC (1988) Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 55:601–610

127.

Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283:482–487

128.

Whittaker RG, Schaefer AM, McFarland R, Taylor RW, Walker M, Turnbull DM (2007) Prevalence and progression of diabetes in mitochondrial disease. Diabetologia 50:2085–2089

129.

Wibrand F, Ravn K, Schwartz M, Rosenberg T, Horn N, Vissing J (2001) Multisystem disorder associated with a missense mutation in the mitochondrial cytochrome b gene. Ann Neurol 50:540–543

130.

Yaffe MP (1999) The machinery of mitochondrial inheritance and behaviour. Science 283:1493–1497

131.

Zeviani M, Moraes CT, DiMauro S, Nakase H, Bonilla E, Schon EA (1988) Deletions of mitochondrial DNA in Kearns–Sayre syndrome. Neurology 38:1339–1346

132.

Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, Di Donato S (1989) An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 339:309–311

133.

Zeviani M, Gellera C, Antozzi C, Rimoldi M, Morandi L, Villani F, Tiranti V, DiDonato S (1991) Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNALeu(UUR). Lancet 338:143–147

134.

Zeviani M, Petruzzella V, Carrozzo R (1997) Disorders of nuclear-mitochondrial intergenomic signalling. J Bioenerg Biomembr 29:121–130

135.

Zeviani M, Di Donato S (2004) Mitochondrial disorders. Brain 127:2153–2172

136.

Zeviani M (2008) OPA1 mutations and mitochondrial DNA damage: keeping the magic circle in shape. Brain 131:314–317

Titel: Multisystem manifestations of mitochondrial disorders
verfasst von: Stefano Di Donato
Publikationsdatum: 01.05.2009
Verlag: D. Steinkopff-Verlag
Erschienen in: Journal of Neurology / Ausgabe 5/2009
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-009-5028-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2009

Prednisone 10 days on/10 days off in patients with Duchenne muscular dystrophy

Specific electron transport chain abnormalities in amyotrophic lateral sclerosis

Vestibular migraine: a critical review of treatment trials

Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer’s disease

Erwin Gustav Niessl von Mayendorf (1873–1943)